DENVER (GenomeWeb News) – As researchers get ready to wrap up the pilot phase of the Cancer Genome Atlas later this year, they're gearing up for the second phase of the project, which will likely involve sequencing roughly 20 to 25 tumor types in the next five years. Second-generation sequencing methods are playing an increasing role in this effort, attendees heard at the American Association for Cancer Research meeting here in Denver yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.